Penicillinolide A: A new anti-inflammatory metabolite from the marine fungus Penicillium sp. SF-5292

39Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

In the course of studies on bioactive metabolites from marine fungi, a new 10-membered lactone, named penicillinolide A (1) was isolated from the organic extract of Penicillium sp. SF-5292 as a potential anti-inflammatory compound. The structure of penicillinolide A (1) was mainly determined by analysis of NMR and MS data and Mosher's method. Penicillinolide A (1) inhibited the production of NO and PGE2 due to inhibition of the expression of iNOS and COX-2. Penicillinolide A (1) also reduced TNF-α, IL-1β and IL-6 production, and these anti-inflammatory effects were shown to be correlated with the suppression of the phosphorylation and degradation of IκB-α, NF-κB nuclear translocation, and NF-κB DNA binding activity. In addition, using inhibitor tin protoporphyrin (SnPP), a competitive inhibitor of HO activity, it was verified that the inhibitory effects of compound 1 on the production of pro-inflammatory mediators and NF-κB DNA binding activity were partially associated with HO-1 expression through Nrf2 nuclear translocation. © 2013 by the authors; licensee MDPI.

Cite

CITATION STYLE

APA

Lee, D. S., Ko, W., Quang, T. H., Kim, K. S., Sohn, J. H., Jang, J. H., … Oh, H. (2013). Penicillinolide A: A new anti-inflammatory metabolite from the marine fungus Penicillium sp. SF-5292. Marine Drugs, 11(11), 4510–4526. https://doi.org/10.3390/md11114510

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free